Elevation of the neurotoxin quinolinic acid occurs following spinal cord trauma.
Excitatory amino acid neurotoxicity and the inflammatory response are suspected as mediators of some of the pathological sequelae occurring as a result of spinal cord injury. Here we report temporal and regional increases of the NMDA receptor agonist, quinolinic acid (QUIN), in an experimental model of spinal contusion injury. These changes occurred at a time when the blood-brain barrier is known to be dysfunctional and the activation state and density of microglia and macrophages are increased. Thus, alterations in tissue QUIN levels may occur as a result of secondary activation of CNS inflammatory cells or from peripherally derived sources across a damaged blood-brain barrier.
Popovich
P G
PG
Department of Physiology, College of Medicine, Ohio State University, Columbus 43210.
Reinhard
J F
JF
Flanagan
E M
EM
Stokes
B T
BT
D000818:Animals; D001812:Blood-Brain Barrier / Q000502:physiology; D005260:Female; D007150:Immunohistochemistry; D008264:Macrophages / Q000502:physiology; D017628:Microglia / Q000502:physiology; D017378:Quinolinic Acid / Q000097:blood / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D016194:Receptors, N-Methyl-D-Aspartate / Q000502:physiology; D013116:Spinal Cord / Q000378:metabolism; D013119:Spinal Cord Injuries / Q000378:metabolism*
D016194:Receptors, N-Methyl-D-Aspartate; D017378:Quinolinic Acid